Publication
Noninvasive Fluorine-19 Magnetic Resonance Relaxometry Measurement of the Partial Pressure of Oxygen in Acellular Perfluorochemical-loaded Alginate Microcapsules Implanted in the Peritoneal Cavity of Nonhuman Primates
Downloadable Content
- Persistent URL
- Last modified
- 05/22/2025
- Type of Material
- Authors
- Language
- English
- Date
- 2020-02-01
- Publisher
- Lippincott Williams & Wilkins
- Publication Version
- Copyright Statement
- © 2019 Wolters Kluwer Health, Inc. All rights reserved.
- License
- Final Published Version (URL)
- Title of Journal or Parent Work
- Volume
- 104
- Issue
- 2
- Start Page
- 259
- End Page
- 269
- Grant/Funding Information
- And by generous gifts from Malcolm and Musette Powell and from Maxine Clippert.
- National Institutes of Health (P41 EB015894 and S10 RR023730),
- This study was supported by a grant from the Juvenile Diabetes Research Foundation (Strategic Research Agreement),
- Minnesota Lions Diabetes Foundation, the Schott Family Foundation, the Carol Olson Memorial Diabetes Research Fund,
- Abstract
- Background. We have utilized a noninvasive technique for measuring the partial pressure of oxygen (pO2) in alginate microcapsules implanted intraperitoneally in healthy nonhuman primates (NHPs). Average pO2 is important for determining if a transplant site and capsules with certain passive diffusion characteristics can support the islet viability, metabolic activity, and dose necessary to reverse diabetes. Methods. Perfluoro-15-crown-5-ether alginate capsules were infused intraperitoneally into 3 healthy NHPs. Peritoneal pO2 levels were measured on days 0 and 7 using fluorine-19 magnetic resonance relaxometry and a fiber-optic probe. Fluorine-19 MRI was used to determine the locations of capsules within the peritoneal space on days 0 and 7. Gross and histologic evaluations of the capsules were used to assess their biocompatibility postmortem. Results. At day 0 immediately after infusion of capsules equilibrated to room air, capsules were concentrated near the infusion site, and the pO2 measurement using magnetic resonance relaxometry was 147 ± 9 mm Hg. On day 7 after capsules were dispersed throughout the peritoneal cavity, the pO2 level was 61 ± 11 mm Hg. Measurements using the fiber-optic oxygen sensor were 132 ± 7.5 mm Hg (day 0) and 89 ± 6.1 mm Hg (day 7). Perfluoro-15-crown-5-ether capsules retrieved on day 7 were intact and free-floating without host cell attachment, although the numbers of peritoneal CD20+ B cells, CD4+ and CD8+ T cells, and CD14+ macrophages increased consistent with a mild foreign body reaction. Conclusions. The peritoneal pO2 of normal NHPs is relatively low and we predict would decrease further when encapsulated islets are transplanted intraperitoneally.
- Author Notes
- Keywords
- Research Categories
- Health Sciences, Medicine and Surgery
- Health Sciences, Radiology
- Health Sciences, Immunology
Tools
- Download Item
- Contact Us
-
Citation Management Tools
Relations
- In Collection:
Items
| Thumbnail | Title | File Description | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|---|
|
|
Publication File - vs6fv.pdf | Primary Content | 2025-05-08 | Public | Download |